Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EPS (Basic) (2017 - 2025)

Catheter Precision (VTAK) has disclosed EPS (Basic) for 9 consecutive years, with -$1.7 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) rose 95.55% to -$1.7 in Q3 2025 year-over-year; TTM through Sep 2025 was $38.22, a 184.33% increase, with the full-year FY2024 number at -$6.68, up 94.86% from a year prior.
  • EPS (Basic) was -$1.7 for Q3 2025 at Catheter Precision, down from -$0.38 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $40.66 in Q4 2024 to a low of -$232.69 in Q4 2021.
  • A 5-year average of -$16.36 and a median of -$1.7 in 2025 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): plummeted 88624.26% in 2023, then skyrocketed 3439.75% in 2024.
  • Catheter Precision's EPS (Basic) stood at -$232.69 in 2021, then skyrocketed by 100.87% to $2.02 in 2022, then crashed by 160.27% to -$1.22 in 2023, then surged by 3439.75% to $40.66 in 2024, then crashed by 104.18% to -$1.7 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EPS (Basic) are -$1.7 (Q3 2025), -$0.38 (Q2 2025), and -$0.36 (Q1 2025).